Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Eileen Dolan

Showing results (1-10 of 180) with videos related to

Pageof 18
Sort By:
Pharmacogenomics|January 23, 2026
The role of pharmacogenomics in managing cisplatin toxicityM Eileen Dolan
Current Drug Metabolism|April 2, 2011
Clinically relevant genetic variations in drug metabolizing enzymesNavin Pinto, M Eileen Dolan
Bioinformation|March 5, 2008
On the challenges of the HapMap resourceWei Zhang, M Eileen Dolan
Pharmacogenomics|May 10, 2008
Ancestry-related differences in gene expression: findings may enhance understanding of health disparities between populationsWei Zhang, M Eileen Dolan
Current Pharmaceutical Design|November 21, 2009
Use of cell lines in the investigation of pharmacogenetic lociWei Zhang, M Eileen Dolan
Pharmacogenomics|February 9, 2010
Impact of the 1000 genomes project on the next wave of pharmacogenomic discoveryWei Zhang, M Eileen Dolan
Current Bioinformatics|September 28, 2011
Beyond the HapMap Genotypic Data: Prospects of Deep Resequencing ProjectsWei Zhang, M Eileen Dolan
Evolutionary Bioinformatics Online|November 26, 2008
Exploring the evolutionary history of the differentially expressed genes between human populations: action of recent positive selectionWei Zhang, M Eileen Dolan
Current Opinion in Oncology|November 19, 2003
Temozolomide: realizing the promise and potentialR Nagasubramanian, M Eileen Dolan
Current Opinion in Molecular Therapeutics|December 15, 2010
The emerging role of microRNAs in drug responsesWei Zhang, M Eileen Dolan
Pageof 18

Showing results (1-10 of 180) with videos related to

Sort By:
Pageof 18
Pharmacogenomics|January 23, 2026
The role of pharmacogenomics in managing cisplatin toxicityM Eileen Dolan
Current Drug Metabolism|April 2, 2011
Clinically relevant genetic variations in drug metabolizing enzymesNavin Pinto, M Eileen Dolan
Bioinformation|March 5, 2008
On the challenges of the HapMap resourceWei Zhang, M Eileen Dolan
Pharmacogenomics|May 10, 2008
Ancestry-related differences in gene expression: findings may enhance understanding of health disparities between populationsWei Zhang, M Eileen Dolan
Current Pharmaceutical Design|November 21, 2009
Use of cell lines in the investigation of pharmacogenetic lociWei Zhang, M Eileen Dolan
Pharmacogenomics|February 9, 2010
Impact of the 1000 genomes project on the next wave of pharmacogenomic discoveryWei Zhang, M Eileen Dolan
Current Bioinformatics|September 28, 2011
Beyond the HapMap Genotypic Data: Prospects of Deep Resequencing ProjectsWei Zhang, M Eileen Dolan
Evolutionary Bioinformatics Online|November 26, 2008
Exploring the evolutionary history of the differentially expressed genes between human populations: action of recent positive selectionWei Zhang, M Eileen Dolan
Current Opinion in Oncology|November 19, 2003
Temozolomide: realizing the promise and potentialR Nagasubramanian, M Eileen Dolan
Current Opinion in Molecular Therapeutics|December 15, 2010
The emerging role of microRNAs in drug responsesWei Zhang, M Eileen Dolan
Pageof 18